Skip to main content
. 1999 Sep 6;190(5):651–668. doi: 10.1084/jem.190.5.651

Table 3.

Frequency of Peptide-specific CTLp Directed to Flu Matrix58–66 in the Context of HLA-A*0201 in Melanoma Patients and Healthy Donors

Subject Frequency of CTLp to Flu matrix58–66 peptide
Patient 3 1/4,195
Patient 4 1/7,426
Patient 5 1/6,967
Patient 7 1/5,471
Patient 8 1/4,435
Healthy donor 1 1/10,506
Healthy donor 2 1/5,591
Healthy donor 3 1/13,177
Healthy donor 4 1/15,246
Healthy donor 5 1/7,588
Healthy donor 6 1/13,440

CTLp frequency was evaluated in peripheral blood by LDA as described in Materials and Methods using peptide-loaded T2 cells as APCs. Results are expressed as peptide-specific CTLp/PBLs.